The αβ T‐cell receptor binds to a combination of MHC and peptide - pediagenosis
Article Update

Wednesday, August 26, 2020

The αβ T‐cell receptor binds to a combination of MHC and peptide

The αβ T‐cell receptor binds to a combination of MHC and peptide
When soluble TCR preparations produced using recombinant DNA technology are immobilized on a sensor chip, they can bind MHC–peptide complex specifically with rather low affinities (Ka) in the 104–107 M−1 range. This low affinity and the relatively small number of atomic contacts formed between the TCRs and their MHC–peptide ligands when T‐cells contact their target cell make the contribution of TCR recognition to the binding energy of this cellular interaction fairly trivial. The brunt of the attraction rests on the antigen‐independent major adhesion molecule pairs, such as LFA‐1 − ICAM‐1 and CD2 − LFA‐3 that are recruited into the immunological synapse (see Figure 7.20), but any subsequent triggering of the T‐cell by MHC–peptide antigen must involve signaling through the T‐cell receptor.

Topology of the ternary complex
Of the three complementarity determining regions present in each TCR chain, CDR1 and CDR2 are much less variable than CDR3. Unlike immunoglobulins, somatic hypermutation does not occur in TCR genes, so variability in CDR1 and CDR2 is limited by the number of germline V genes. However, just like in immunoglobulin, the TCR CDR3 is encoded by a V(D)J sequence that results from combinatorial and nucleotide insertion mechanisms. As the MHC sequences in a given individual are fixed, whereas there will be a large number of different peptide sequences, a logical model would have CDR1 and CDR2 of each TCR chain contacting the α‐helices at the tip of the MHC peptide‐binding groove, and the much more variable CDR3 contacting the peptide. In accord with this view, several studies have shown that T‐cells that recognize small variations in a peptide in the context of a given MHC molecule differ only in their CDR3 regions.

The combining sites of the TCRs are generally relatively flat (Figure 5.21), which would be expected given the need for complementarity to the gently undulating surface of the peptide–MHC combination (Figure 5.22a). In most of the structures so far solved, recognition involves the TCR lying either diagonally (Figure 5.22b) or orthogonally (Figure 5.22c) across the peptide–MHC with the TCR Vα CDR1 and CDR2 overlying the MHC class II β1‐helix or class I α2‐helix, and the Vβ CDR1 and CDR2 overlying the α1‐helix of MHC class I or class II (Figure 5.23). The more variable CDR3 regions make contact with the peptide, particularly focusing in on the middle residues (P4 to P6). There is evidence to suggest that the TCR initially binds to the MHC in a fairly peptide‐independent fashion, followed by conformational changes particularly in the peptiderecognizing CDR3 loops of the TCR to permit optimal contact with the peptide. Activation through the TCR‐CD3 complex can operate if these adjustments permit more stable and multimeric binding. The CD4 or CD8 co‐receptor for MHC binds to nonpolymorphic residues present in the α2 and β2 domains of class II (Figure 5.24), and in the α3 domain of class I, respectively.
Figure 5.22 Complementarity between MHC–peptide and Tcell receptor. (a) Backbone structure of a TCR (2C) recognizing a peptide (called dEV8) presented by the MHC class I molecule H2Kb. The TCR is in the top half of the picture, with the α chain in pink and its CDR1 colored magenta, CDR2 purple, and CDR3 yellow. The β chain is colored light blue with its CDR1 cyan, CDR2 navy blue, CDR3 green, and the fourth hypervariable loop orange. Below the TCR is the MHC α chain in green and β2microglobulin in dark green. The peptide with sidechains at positions P1, P4, and P8 is colored yellow. (Source: (a) Garcia K.C. et al. (1998) Science 279, 1166–1172.). (b) The same complex looking down onto a molecular surface representation of the H2Kb in yellow, with the diagonal docking mode of the TCR in a backbone worm representation colored pink. The peptide is drawn in a ball and stick format. (c) By contrast, here we see the orthogonal docking mode of a TCR (called D10) recognizing a conalbuminderived peptide presented by MHC class II. The TCR backbone worm representation shows the Vα in green and Vβ in blue, and the IAk class II molecular surface representation has the α chain in light green and the β chain in orange, holding the peptide. (Source: (b,c) Reinherz E.L. et al. (1999) Science 286, 1913–1921. Reproduced with on of AAAS.)

Figure 5.23 TCR CDR3 recognition of peptide presented by MHC. (a) Contacts between the CDR1–3 loops of the α and β chains of a Tcell receptor (TCR) and a spacefilling surface of MHC and peptide. The example shown here is a mouse TCR bound to the H2 IAb presenting a 13mer peptide. The α1 region of MHC is colored cyan, the β1 or α2 region of MHC magenta and the peptide yellow. The CDR loops of the TCR α and β chains are indicated (α1 is CDR1 of the α chain, and so on). (b) Elevation perspective of the interactions. (Source: Marrack P. et al. (2008) Annual Review of Immunology 26, 171–203. Reproduced with permission of Annual Reviews.)

Figure 5.24 The TCR–peptide–MHC–CD4 complex. Ribbon diagram of the complex oriented as if the TCR (MS2–3C8) and CD4 molecules are attached to the Tcell at the bottom and the MHC class II molecule (HLADR4) is attached to an opposing APC at the top. TCR α chain, blue; TCR β chain, green; CD4, pink; MHC α chain, gray; MHC β chain, yellow; peptide (derived from myelin basic protein), red. (Source: Yin Y. et al. (2012) Proceedings of the National Academy of Sciences of the USA. 109, 5405–5410. Reproduced with permission.)

MHC class I‐like molecules
In addition to the highly polymorphic classical MHC class I molecules (HLA‐A, ‐B, and ‐C in the human and H‐2 K,‐D, and ‐L in the mouse), there are other loci encoding peptide‐ presenting MHC molecules containing β2‐microglobulin with relatively nonpolymorphic heavy chains. These are H‐2 M3,‐Qa, and ‐Q in mice, and HLA‐E, ‐F, and ‐G in humans.In addition there are a number of specialized MHC homologs, including the T10 and T22 molecules which act as ligands for γδ T‐cells, that do not present peptides and are present in mice but not in humans.
The H‐2 M3 molecule is unusual in that its peptide‐binding groove has many nonpolar amino acids designed to facilitate the binding of the characteristic hydrophobic N‐formylmethionine residue of peptides derived from bacterial proteins, which can then be presented to T‐cells. Expression of H‐2 M3 is limited by the availability of these peptides so that high levels are only seen during prokaryotic infections. Discussion of the role of HLA‐G expression in the human extravillous cytotrophoblast will arise in Chapter 15.

Share with your friends

Give us your opinion
This is just an example, you can fill it later with your own note.